{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:14:49Z","timestamp":1750220089504,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":40,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,7]]},"DOI":"10.1145\/3510427.3510445","type":"proceedings-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T23:45:18Z","timestamp":1646351118000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the Mechanism of Chemical Drugs on Neurodegenerative Diseases"],"prefix":"10.1145","author":[{"given":"YiYang","family":"Shen","sequence":"first","affiliation":[{"name":"Eastbourne College, UK"}]}],"member":"320","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.160040"},{"key":"e_1_3_2_1_2_1","volume-title":"Retrieved","author":"Berman T.","year":"2018","unstructured":"Berman , T. and Bayati , Armin. 2018 . December. What are neurodegenerative diseases and how do they affect the brain . Retrieved June 25, 2021, form https:\/\/kids.frontiersin.org\/articles\/10.3389\/frym.2018.00070 Berman, T. and Bayati, Armin. 2018. December. What are neurodegenerative diseases and how do they affect the brain. Retrieved June 25, 2021, form https:\/\/kids.frontiersin.org\/articles\/10.3389\/frym.2018.00070"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Goedert M. 2015. Neurodegeneration. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A\u03b2 tau and \u03b1-synuclein. Science (New York N.Y.) 349(6248) 1255555  Goedert M. 2015. Neurodegeneration. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A\u03b2 tau and \u03b1-synuclein. Science (New York N.Y.) 349(6248) 1255555","DOI":"10.1126\/science.1255555"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"crossref","unstructured":"DeTure M. A and Dickson D. W. 2019. The neuropathological diagnosis of Alzheimer's disease. Molecular neurodegeneration 14(1) 32.  DeTure M. A and Dickson D. W. 2019. The neuropathological diagnosis of Alzheimer's disease. Molecular neurodegeneration 14(1) 32.","DOI":"10.1186\/s13024-019-0333-5"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Tarawneh R. and Holtzman D. M. 2012. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harbor perspectives in medicine 2(5) a006148.  Tarawneh R. and Holtzman D. M. 2012. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harbor perspectives in medicine 2(5) a006148.","DOI":"10.1101\/cshperspect.a006148"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000055"},{"key":"e_1_3_2_1_7_1","unstructured":"National Institute on Aging. 2021. Parkinson's Disease. Retrieved July 5 2021 from https:\/\/www.nia.nih.gov\/health\/parkinsons-disease  National Institute on Aging. 2021. Parkinson's Disease. Retrieved July 5 2021 from https:\/\/www.nia.nih.gov\/health\/parkinsons-disease"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Alexander G. E. 2004. Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues in clinical neuroscience 6(3) 259\u2013280.  Alexander G. E. 2004. Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues in clinical neuroscience 6(3) 259\u2013280.","DOI":"10.31887\/DCNS.2004.6.3\/galexander"},{"key":"e_1_3_2_1_9_1","volume-title":"Alzheimer's Society's view on demography. Retrieved","author":"Alzheimer's Society","year":"2021","unstructured":"Alzheimer's Society . 2021. Alzheimer's Society's view on demography. Retrieved 5 July , 2021 , from https:\/\/www.alzheimers.org.uk\/about-us\/policy-and-influencing\/what-we-think\/demography Alzheimer's Society. 2021. Alzheimer's Society's view on demography. Retrieved 5 July, 2021, from https:\/\/www.alzheimers.org.uk\/about-us\/policy-and-influencing\/what-we-think\/demography"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"crossref","unstructured":"Qiu C. Kivipelto M. and Von Strauss E. 2009. Epidemiology of Alzheimer's disease: occurrence determinants and strategies toward intervention. Dialogues in clinical neuroscience 11(2) 111\u2013128.  Qiu C. Kivipelto M. and Von Strauss E. 2009. Epidemiology of Alzheimer's disease: occurrence determinants and strategies toward intervention. Dialogues in clinical neuroscience 11(2) 111\u2013128.","DOI":"10.31887\/DCNS.2009.11.2\/cqiu"},{"key":"e_1_3_2_1_11_1","volume-title":"Retrieved","author":"Parkinson's Foundation","year":"2021","unstructured":"Parkinson's Foundation . 2021. Statistics . Retrieved July 6, 2021 , from https:\/\/www.parkinson.org\/Understanding-Parkinsons\/Statistics Parkinson's Foundation. 2021. Statistics. Retrieved July 6, 2021, from https:\/\/www.parkinson.org\/Understanding-Parkinsons\/Statistics"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Mayeux R. and Stern Y. 2012. Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine 2(8) a006239.  Mayeux R. and Stern Y. 2012. Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine 2(8) a006239.","DOI":"10.1101\/cshperspect.a006239"},{"key":"e_1_3_2_1_13_1","volume-title":"Retrieved","author":"Alzheimer","year":"2021","unstructured":"Alzheimer . 2021 . International work - Alzheimer . Retrieved July 24, 2021, from https:\/\/alzheimer.ie\/creating-change\/policy-on-dementia-in-ireland\/international-work\/ Alzheimer. 2021. International work - Alzheimer. Retrieved July 24, 2021, from https:\/\/alzheimer.ie\/creating-change\/policy-on-dementia-in-ireland\/international-work\/"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Yang W. Hamilton J. Kopil C. Beck J. Tanner C. Albin R. Ray Dorsey E. Dahodwala N. Cintina I. Hogan P. and Thompson T. 2020. Current and projected future economic burden of Parkinson's disease in the U.S. npj Parkinson's Disease 6  Yang W. Hamilton J. Kopil C. Beck J. Tanner C. Albin R. Ray Dorsey E. Dahodwala N. Cintina I. Hogan P. and Thompson T. 2020. Current and projected future economic burden of Parkinson's disease in the U.S. npj Parkinson's Disease 6","DOI":"10.1038\/s41531-020-0117-1"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"crossref","unstructured":"Sun X. Chen W. and Wang Y. 2015. \u03b2-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease. Frontiers in Pharmacology 6.  Sun X. Chen W. and Wang Y. 2015. \u03b2-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease. Frontiers in Pharmacology 6.","DOI":"10.3389\/fphar.2015.00221"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"crossref","unstructured":"O'Brien R. J. and Wong P. C. 2011. Amyloid precursor protein processing and Alzheimer's disease. Annual review of neuroscience 34 185\u2013204.  O'Brien R. J. and Wong P. C. 2011. Amyloid precursor protein processing and Alzheimer's disease. Annual review of neuroscience 34 185\u2013204.","DOI":"10.1146\/annurev-neuro-061010-113613"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.05.004"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.536839"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-05718-5"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom6010006"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200421070-00004"},{"key":"e_1_3_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2004.12.048"},{"key":"e_1_3_2_1_23_1","unstructured":"Cacabelos R. 2007. Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics. Neuropsychiatric disease and treatment 3(3) 303\u2013333.  Cacabelos R. 2007. Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics. Neuropsychiatric disease and treatment 3(3) 303\u2013333."},{"key":"e_1_3_2_1_24_1","unstructured":"Mitra A. n.d. Therapeutic Interventions in Alzheimer Disease.  Mitra A. n.d. Therapeutic Interventions in Alzheimer Disease."},{"key":"e_1_3_2_1_25_1","unstructured":"Casey D. A. Antimisiaris D. and O'Brien J. 2010. Drugs for Alzheimer's disease: are they effective?. P & T : a peer-reviewed journal for formulary management 35(4) 208\u2013211.  Casey D. A. Antimisiaris D. and O'Brien J. 2010. Drugs for Alzheimer's disease: are they effective?. P & T : a peer-reviewed journal for formulary management 35(4) 208\u2013211."},{"key":"e_1_3_2_1_26_1","volume-title":"Retrieved","author":"National Institute on Aging.","year":"2021","unstructured":"National Institute on Aging. 2021 . How Is Alzheimer's Disease Treated? . Retrieved July 21, 2021, from https:\/\/www.nia.nih.gov\/health\/how-alzheimers-disease-treated National Institute on Aging. 2021. How Is Alzheimer's Disease Treated?. Retrieved July 21, 2021, from https:\/\/www.nia.nih.gov\/health\/how-alzheimers-disease-treated"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"crossref","unstructured":"Colovi\u0107 M. B. Krsti\u0107 D. Z. Lazarevi\u0107-Pa\u0161ti T. D. Bond\u017ei\u0107 A. M. and Vasi\u0107 V. M. 2013. Acetylcholinesterase inhibitors: pharmacology and toxicology. Current neuropharmacology 11(3) 315\u2013335.  Colovi\u0107 M. B. Krsti\u0107 D. Z. Lazarevi\u0107-Pa\u0161ti T. D. Bond\u017ei\u0107 A. M. and Vasi\u0107 V. M. 2013. Acetylcholinesterase inhibitors: pharmacology and toxicology. Current neuropharmacology 11(3) 315\u2013335.","DOI":"10.2174\/1570159X11311030006"},{"key":"e_1_3_2_1_28_1","unstructured":"Centerwatch.com. 2021. Namenda (memantine HCl). Retrieved July 8 2021 from https:\/\/www.centerwatch.com\/directories\/1067-fda-approved-drugs\/listing\/3864-namenda-memantine-hcl  Centerwatch.com. 2021. Namenda (memantine HCl). Retrieved July 8 2021 from https:\/\/www.centerwatch.com\/directories\/1067-fda-approved-drugs\/listing\/3864-namenda-memantine-hcl"},{"key":"e_1_3_2_1_29_1","unstructured":"Pubchem.ncbi.nlm.nih.gov. 2021. Levodopa. Retrieved July 8 2021 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Levodopa  Pubchem.ncbi.nlm.nih.gov. 2021. Levodopa. Retrieved July 8 2021 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Levodopa"},{"volume-title":"Parkinson's disease - Treatment. Retrieved","year":"2021","key":"e_1_3_2_1_30_1","unstructured":"nhs.uk. 2021. Parkinson's disease - Treatment. Retrieved July 9, 2021 , from https:\/\/www.nhs.uk\/conditions\/parkinsons-disease\/treatment\/ nhs.uk. 2021. Parkinson's disease - Treatment. Retrieved July 9, 2021, from https:\/\/www.nhs.uk\/conditions\/parkinsons-disease\/treatment\/"},{"key":"e_1_3_2_1_31_1","first-page":"91","article-title":"Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease","volume":"22","author":"Youdim M. B.","year":"1986","unstructured":"Youdim M. B. 1986 . Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease . Journal of neural transmission. Supplementum , 22 , 91 \u2013 105 . Youdim M. B. 1986. Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease. Journal of neural transmission. Supplementum, 22, 91\u2013105.","journal-title":"Journal of neural transmission. Supplementum"},{"key":"e_1_3_2_1_32_1","volume-title":"Retrieved","author":"En","year":"2021","unstructured":"En .m.wikipedia.org. 2021 . Catechol-O-methyltransferase inhibitor - Wikipedia . Retrieved July 21, 2021, from https:\/\/en.m.wikipedia.org\/wiki\/Catechol-O-methyltransferase_inhibitor En.m.wikipedia.org. 2021. Catechol-O-methyltransferase inhibitor - Wikipedia. Retrieved July 21, 2021, from https:\/\/en.m.wikipedia.org\/wiki\/Catechol-O-methyltransferase_inhibitor"},{"key":"e_1_3_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111623"},{"key":"e_1_3_2_1_34_1","doi-asserted-by":"crossref","unstructured":"Cao J. Hou J. Ping J. and Cai D. 2018. Advances in developing novel therapeutic strategies for Alzheimer's disease. Molecular neurodegeneration 13(1) 64.  Cao J. Hou J. Ping J. and Cai D. 2018. Advances in developing novel therapeutic strategies for Alzheimer's disease. Molecular neurodegeneration 13(1) 64.","DOI":"10.1186\/s13024-018-0299-8"},{"key":"e_1_3_2_1_35_1","unstructured":"Alzforum.org. 2021. LMTM | ALZFORUM. Retrieved July 9 2021 from https:\/\/www.alzforum.org\/therapeutics\/lmtm  Alzforum.org. 2021. LMTM | ALZFORUM. Retrieved July 9 2021 from https:\/\/www.alzforum.org\/therapeutics\/lmtm"},{"key":"e_1_3_2_1_36_1","volume-title":"Behind the headlines: Is a new Alzheimer's treatment in sight? | Alzheimer's Research UK. Retrieved","author":"Alzheimer's Research UK.","year":"2021","unstructured":"Alzheimer's Research UK. 2021. Behind the headlines: Is a new Alzheimer's treatment in sight? | Alzheimer's Research UK. Retrieved July 9, 2021 , from https:\/\/www.alzheimersresearchuk.org\/blog\/behind-the-headlines-is-a-new-alzheimers-treatment-in-sight\/ Alzheimer's Research UK. 2021. Behind the headlines: Is a new Alzheimer's treatment in sight? | Alzheimer's Research UK. Retrieved July 9, 2021, from https:\/\/www.alzheimersresearchuk.org\/blog\/behind-the-headlines-is-a-new-alzheimers-treatment-in-sight\/"},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.160040"},{"key":"e_1_3_2_1_38_1","unstructured":"Vogenberg F. R. Isaacson Barash C. and Pursel M. 2010. Personalized medicine: part 1: evolution and development into theranostics. P & T : a peer-reviewed journal for formulary management 35(10) 560\u2013576.  Vogenberg F. R. Isaacson Barash C. and Pursel M. 2010. Personalized medicine: part 1: evolution and development into theranostics. P & T : a peer-reviewed journal for formulary management 35(10) 560\u2013576."},{"issue":"2","key":"e_1_3_2_1_39_1","first-page":"82","article-title":"A Machine Learning Approach for Gene Regulatory Network Inference","volume":"9","author":"Meroua Daoudi","year":"2019","unstructured":"Meroua Daoudi , Souham Meshoul, and Fariza Tahi . 2019 . \" A Machine Learning Approach for Gene Regulatory Network Inference ,\" International Journal of Bioscience, Biochemistry and Bioinformatics vol. 9 , no. 2 , 82 - 89 Meroua Daoudi, Souham Meshoul, and Fariza Tahi. 2019. \"A Machine Learning Approach for Gene Regulatory Network Inference,\" International Journal of Bioscience, Biochemistry and Bioinformatics vol. 9, no. 2, 82-89","journal-title":"International Journal of Bioscience, Biochemistry and Bioinformatics"},{"key":"e_1_3_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.17706\/ijbbb.2019.9.1.35-41"}],"event":{"name":"ICBBB '22: 2022 12th International Conference on Bioscience, Biochemistry and Bioinformatics","acronym":"ICBBB '22","location":"Tokyo Japan"},"container-title":["2022 12th International Conference on Bioscience, Biochemistry and Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3510427.3510445","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3510427.3510445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T18:09:46Z","timestamp":1750183786000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3510427.3510445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":40,"alternative-id":["10.1145\/3510427.3510445","10.1145\/3510427"],"URL":"https:\/\/doi.org\/10.1145\/3510427.3510445","relation":{},"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"2022-03-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}